| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/14/2002 | US20020019538 Prevention binding of transcription factor tozinc finger binding compounds |
| 02/14/2002 | US20020019537 Novel processes for preparing torsemide intermediate |
| 02/14/2002 | US20020019527 Antitumor, antcarcinogenic agents |
| 02/14/2002 | US20020019525 Pyrido [2,3-b] indolizine derivatives and aza analogues thereof; CRF1 specific ligands |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/14/2002 | US20020019401 Psychological disorders; adjustment of dopamine concentration |
| 02/14/2002 | US20020019393 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
| 02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | US20020018809 Analgesics; rheumatic diseases; muscular disorders; sleep disorders |
| 02/14/2002 | DE10038007A1 Neue Amino-und Amido-Diphenylether für Arzneimittel New amino and amido diphenyl ether for drugs |
| 02/14/2002 | DE10037408A1 Verfahren zur Herstellung von basisch reagierenden, organischen, stickstoffhaltigen Verbindungen durch Reduktion mit Lithiumaluminiumhydrid Process for the preparation of basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 02/14/2002 | DE10035991A1 Nagellackzusammensetzung Nail polish composition |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418912A1 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 02/13/2002 | EP1178963A1 Ion channel modulating agents |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178784A1 New pharmaceutical combinations for nos inhibitors |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/12/2002 | US6346623 Ozonolysis of quinoline, oxidation with oxygen or air and decomposition of peroxide and pyridinecarboxylic acid |
| 02/12/2002 | US6346550 Hydroxylation activated prodrugs |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346541 Antitumor and anticarcinogenic agents for breast, lung, and skin cancer |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/12/2002 | CA2024399C Compounds |
| 02/07/2002 | WO2002010431A2 Functional biopolymer modification reagents and uses thereof |
| 02/07/2002 | WO2002010228A2 Transformation of polymers to useful chemicals by oxidation |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010133A1 Tridentate ligands and their complexes with transition metals |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002009759A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | US20020016492 Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones |
| 02/07/2002 | US20020016470 Reacting butyllithium with 2,5-dihalopyridine in a non-coordinating solvent |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016462 Producing 3-amino-1-benzylpyrrolidine and 8-benzyl-2,8-diaza bicyclo(4.3.0)-nonane; reaction mixture added to an aqueous solution in which substances containging alpha-hydroxy carboxyl and/or alpha-aminocarboxyl groups are dissolved |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016425 Bis-aryliminepyridine iron/cobalt complexes as selective catalysts in ethylene oligomerization |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016345 Pyridine ketones useful as herbicides |
| 02/07/2002 | US20020016343 Selective cyclooxygenase-2 inhibitor, useful in treatment of inflammation, pain and fever |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020015883 Ionic liquids |
| 02/07/2002 | US20020015805 Fluoro-substituted alkenyl compounds, liquid crystal compositions, and liquid crystal display elements |
| 02/07/2002 | US20020015687 Method for the anhydrous loading of nicotine onto ion exchange resins |
| 02/07/2002 | DE10122097A1 Pyrazolylbiphenylcarboxamide Pyrazolylbiphenylcarboxamide |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | DE10005853C1 Verfahren zur Herstellung von Bis-(4-amino-1-pyridinium)-alkanen Alkanes process for the preparation of bis (4-amino-1-pyridinium) |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2416307A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | CA2411490A1 Transformation of polymers to useful chemicals by oxidation |
| 02/06/2002 | EP1178042A1 -diketonato-metal complexes and process for the preparation thereof, photoelectric conversion devices and photoelectrochemical cells |
| 02/06/2002 | EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides |
| 02/06/2002 | EP1178035A1 Fungicidal phenylimine derivatives |
| 02/06/2002 | EP1177796A1 Preventives/remedies for liver diseases |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1176960A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP0931084B1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 02/06/2002 | EP0861077B1 Hemoregulatory compounds |
| 02/06/2002 | EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 02/06/2002 | CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/05/2002 | US6344486 Anticoagulants |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 02/05/2002 | US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 02/01/2002 | CA2354275A1 Process for preparing basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 01/31/2002 | WO2002009117A1 Programmable molecular device |
| 01/31/2002 | WO2002008232A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/31/2002 | WO2002008222A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 01/31/2002 | WO2002008221A2 Capsaicin receptor ligands |